Transplant Research Epidemiology Group (TrEG), Australia and New Zealand Dialysis and Transplant (ANZDATA) Registry, South Australian Health and Medical Research Institute (SAHMRI), Adelaide, South Australia, Australia.
Central and Northern Adelaide Renal and Transplantation Service, Royal Adelaide Hospital, Adelaide, South Australia, Australia.
Nephrology (Carlton). 2024 Mar;29(3):143-153. doi: 10.1111/nep.14257. Epub 2023 Nov 28.
Kidney transplantation remains the preferred standard of care for patients with kidney failure. Most patients do not access this treatment and wide variations exist in which patients access transplantation. We sought to develop a model to estimate post-kidney transplant survival to inform more accurate comparisons of access to kidney transplantation.
Development and validation of prediction models using demographic and clinical data from the Australia and New Zealand Dialysis and Transplant Registry. Adult deceased donor kidney only transplant recipients between 2000 and 2020 were included. Cox proportional hazards regression methods were used with a primary outcome of patient survival. Models were evaluated using Harrell's C-statistic for discrimination, and calibration plots, predicted survival probabilities and Akaike Information Criterion for goodness-of-fit.
The model development and validation cohorts included 11 302 participants. Most participants were male (62.8%) and Caucasian (79.2%). Glomerulonephritis was the most common cause of kidney disease (45.6%). The final model included recipient, donor, and transplant related variables. The model had good discrimination (C-statistic, 0.72; 95% confidence interval (CI) 0.70-0.74 in the development cohort, 0.70; 95% CI 0.67-0.73 in the validation cohort and 0.72; 95% CI 0.69-0.75 in the temporal cohort) and was well calibrated.
We developed a statistical model that predicts post-kidney transplant survival in Australian kidney failure patients. This model will aid in assessing the suitability of kidney transplantation for patients with kidney failure. Survival estimates can be used to make more informed comparisons of access to transplantation between units to better measure equity of access to organ transplantation.
肾移植仍然是肾衰竭患者的首选治疗标准。大多数患者无法接受这种治疗,而患者接受移植的途径存在广泛差异。我们试图建立一个模型来估计肾移植后的生存情况,以便更准确地比较肾移植的可及性。
使用澳大利亚和新西兰透析和移植登记处的人口统计学和临床数据开发和验证预测模型。纳入 2000 年至 2020 年间接受成人尸体供肾单器官移植的患者。使用 Cox 比例风险回归方法,以患者生存为主要结局。使用 Harrell's C 统计量评估模型的区分度,校准图、预测生存概率和 Akaike 信息准则评估模型的拟合优度。
模型开发和验证队列包括 11302 名参与者。大多数参与者为男性(62.8%)和白种人(79.2%)。肾小球肾炎是最常见的肾脏疾病病因(45.6%)。最终模型纳入了受者、供者和移植相关变量。该模型具有良好的区分度(C 统计量,发展队列为 0.72(95%置信区间(CI)0.70-0.74),验证队列为 0.70(95%CI 0.67-0.73),时间队列为 0.72(95%CI 0.69-0.75))和良好的校准度。
我们开发了一种预测澳大利亚肾衰竭患者肾移植后生存的统计模型。该模型将有助于评估肾衰竭患者接受肾移植的适宜性。生存估计可用于更准确地比较单位之间的移植可及性,从而更好地衡量器官移植可及性的公平性。